Frequency and activation of CD4+CD25high FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy

International Archives of Allergy and Immunology

Volumn 162, Issue 1, 2013, Pages 16-24

  Stelmaszczyk Emmel, Anna ^a   Zawadzka Krajewska, Anna ^a   Szypowska, Agnieszka ^a   Kulus, Marek ^a   Demkow, Urszula ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Allergy; Children; Flow cytometry; Regulatory T cells

Indexed keywords

CD69 ANTIGEN; CD71 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; CD4+ CD25+ T LYMPHOCYTE; CELL STRUCTURE; CHILD; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLUORESCENCE; FOOD ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CLINICAL FEATURE; FLOW CYTOMETRY; HUMAN CELL; PATHOGENESIS;

ANTIGENS, CD4; ASTHMA; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84879470120     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350769     Document Type: Article

References (40)

1. Palomares O, Yaman G, Azkur AK, Akkoc T, Akdis M, Akdis CA: Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010; 40: 1232-1240.
2. Baecher-Allan C, Viglietta V, Hafler DA: Human CD4+CD25+ regulatory T cells. Semin Immunol 2004; 16: 89-97.
3. Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435-6443.
4. Williams LM, Rudensky AY: Maintenace of the FoxP3-dependent developmental program in mature regulatory T cells requires contiuned expression of FoxP3. Nat Immunol 2007; 8: 277-284.
5. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol 2008; 8: 523-532.
6. Wan YY, Flavell RA: Regulatory T cell functions are subverted and coverted owing to attenuated FoxP3 expression. Nature 2007; 45: 766-770.
7. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
8. Seddiki N, Santner-Nanan B, Martinson J: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-1700.
9. Liu W, Putnam AL, Xu-yu Z: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711.
10. Stelmaszczyk-Emmel A, Jackowska T, Rutkowska- Sak L, Marusak-Banacka M, Wasik M: Identification, frequency, activation and function of CD4+CD25 high FoxP3+ regulatory T cells in children with juvenile idiopathic arthritis. Rheumatol Interantional 2012; 32: 1147-1154.
11. Neckers LM, Cossman J: Transferrin receptor induction in mitogen-stimulated T lymphocytes is required for DNA synthesis and cell division and is regulated by IL-2. Proc Natl Acad Sci USA 1983; 80: 3494-3498.
12. Testi R, D'Ambrosini D, De Maria R, Santoni A: The CD69 receptor: A multipurpose cellsurface trigger for hematopoietic cells. Immunol Today 1994; 15: 479-481.
13. Wing K, Ekmark A, Karlsson H, Rudin A, Suri- Payer E: Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 2002; 106: 190-199.
14. Baecher-Allan C, Wolf E, Hafler DA: Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol 2005; 115: 10-18.
15. Cesana GC, DeRaffele G, Cohen S, Moroziewicz D, Mitcham J, Stoutenburg J, Cheung K, Hesdorffer C, Kim-Schulze S, Kaufman HL: Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin- 2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 2006; 24: 1169- 1177.
16. Global Intiative for Asthma (GINA): Global strategy for asthma management and prevention (updated 2007). pp 1-91. www. ginasthma.org
17. Bousquet J, Khaltaev N, Cruz AA, et al: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 2008; 63(suppl 86):8- 160.
18. Lamas M, Sanz E, Martin-Parras L, Espel E, Sperisen P, Collins M, Silva AG: Glucocorticoid hormones upregulate interleukin 2 receptor alpha gene expression. Cell Immunol 1993; 151: 437-450.
19. Dechant M, Weisner W, Berger S, Peipp M, Beyer T, Schneider-Merck T, Lammerts van Bueren JJ, Bleeker WK, Parren PW, van de Winkel JG, Valerius T: Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies. Cancer Res 2008; 68: 4998-5003.
20. Lee J-H, Yu H-H, Wang L-C, Yang Y-H, Lin Y-T, Chiang B-L: The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 2007; 148: 53-63.
21. Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu R, Oh Y, Li H: A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis. Laryngoscope 2007; 117: 876-880.
22. Zhang Q, Qian FH, Liu H, Zhou LF, Huang M, Zhang XL, Yin KS: Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: Role of inhaled corticosteroid. Chin Med J 2008; 121: 205-212.
23. Adkis M, Verhagen J, Taylor A: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen- specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575.
24. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS: Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-615.
25. Grindebacke H, Wing K, Andersson AC, Suri- Payer E, Rak S, Rudin A: Defective suppression of Th2 cytokines by CD4 + CD25 + regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004; 34: 1364-1372.
26. Geraldes L, Morgado J, Almeida A, Todo- Bom A, Santos P, Paiva A, Cheira C, Pais ML: Expression patterns of HLA-DR+ or HLADR- on CD4+/CD25++/CD127low regulatory T cells in patients with allergy. J Investig Allergol Clin Immunol 2010; 20: 201-209.
27. Karagiannidis C, Akdis M, Holopainen P: Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
28. Shi HZ, Li S, Xie ZF, Qin XJ, Qin X, Zhong XN: Regulatory CD4+CD25+ T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 2004; 113: 172- 178.
29. Wills-Karp M, Santeliz J, Karp CL: The germless theory of allergic disease: Revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
30. Liu H, Komai-Koma M, Xu D, Liew FY: Tolllike receptor 2 signaling modulates the functions of CD4 + CD25 + regulatory T cells. Proc Natl Acad Sci USA 2006; 103: 7048-7053.
31. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M: In vivo switch to IL- 10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205: 2887- 2898.
32. Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O: CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360-367.
33. Cao D, Malmstrom V, Beacher-Allan C, Hafler D, Klareskog L, Trollmo C: Isolation and functional characterization of regulatory CD25 bright CD4 + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-223.
34. Nguyen KD, Vanichsarn C, Fohner A, Nadeau KC: Selective deregulation in chemokine signaling pathways of CD4 + CD25 hi CD127 lo / - regulatory T cells in human allergic asthma. J Allergy Clin Immunol 2009; 123: 933-939.
35. Nguyen KD, Fohner A, Booker JD, Dong C, Krensky AM, Nadeau KC: XCL1 enhances regulatory activities of CD4 + CD25 high CD- 127 low/- T cells in human allergic asthma. J Immunol 2008; 181: 5386-5395.
36. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, Griese M, Krauss- Etschmann S: Quantitative and functional impairment of pulmonary CD4 + CD25 hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119: 1258-1266.
37. Meszaros G, Szalay B, Toldi G, Mezei G, Tamasi L, Vasarhelyi B, Cserhati E, Treszl A: FoxP3+ regulatory T cells in childhood allergic rhinitis and asthma. J Investig Allergol Clin Immunol 2009; 19: 237-252.
38. Oiso N: Regulatory T cells in atopic dermatitis. Recent Pat Inflamm Allergy Drug Discov 2010; 4: 244-248.
39. Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M: Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 2008; 63: 1455-1463.
40. Mamessier E, Milhe F, Guillot C, Birnbaum J, Dupuy P, Lorec A-M, Vervloet D, Magnan A: T cell activation in occupational asthma and rhinitis. Allergy 2007; 62: 162-169.